A Parkinson’s disease therapy delivered through a wearable device eased motor function in some patients with advanced Parkinson’s, according…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
A new clinical trial led by scientists at the Yale School of Medicine is testing whether targeting inflammation in people…
Surgeons and neurologists treating Parkinson’s disease now have a clearer, more personalized window into the human brain, thanks to…
Bezisterim, an experimental oral small molecule that Biovie is developing for people with early-stage Parkinson’s disease, is moving toward Phase…
A new smartphone monitoring tool for people with Parkinson’s disease — designed for those who use an Apple Watch…
Dance-based programs for people with Parkinson’s disease have primarily focused on the effects of such interventions on motor problems,…
Veteran actors Michael J. Fox and Harrison Ford are teaming up to help people better understand how to support a…
Disease-causing mutations in the LRRK2 gene may disrupt iron regulation and promote cell damage, potentially contributing to the loss of…
The American Parkinson Disease Association (APDA) has launched a Spanish-language microsite aimed at expanding access to information and…
Hopledo (IPX203), an extended-release formulation of levodopa and carbidopa sold as Crexont in the U.S., has now won approval…